CytoSorb Reduction of Free Hemoglobin during Cardiac Surgery (REFRESH Trial)
Study for patients undergoing cardiac surgery using CytoSorb
Sponsor: CytoSorbents, Inc
Enrolling: Male and Female Patients
IRB Number: AAAP6954
U.S. Govt. ID: NCT02566525
Contact: Lyn Goldsmith: 212-342-0261 / lg2240@cumc.columbia.edu
Additional Study Information: The purpose of this study is to evaluate the safety and performance of the CytoSorb device to reduce plasma free hemoglobin when used intra-operatively with cardiopulmonary bypass (CPB) in subjects undergoing cardiac surgery.
This study is closed
Investigator
Michael Argenziano, MD, FACS
Do You Qualify?
Are you planning to undergo cardiac surgery? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Lyn Goldsmith
lg2240@cumc.columbia.edu
212-342-0261
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE